Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Beyond the Mehran Risk Score: Predictive Value of Total Ischemic Time for Contrast-Induced Nephropathy in ST Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention.

NCT07826572 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT07826572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07826572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Beyond the Mehran Risk Score: Predictive Value of Total Ischemic Time for Contrast-Induced Nephropathy in ST Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention.
Lead sponsor
Assiut University
Phase
Observational
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
August 25, 2028
Enrollment
400 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, contrast induced nephropathy (cin), st elevation (stemi) myocardial infarction